Cloned (Comment) | Organism |
---|---|
gene cofC, recombinant expression in Escherichia coli | Methanocaldococcus jannaschii |
gene fbiD, recombinant expression in Escherichia coli | Mycobacterium tuberculosis |
Crystallization (Comment) | Organism |
---|---|
native structure, to 1.99 A resolution, in complex with phosphoenolpyruvate, to 2.18 A resolution | Mycobacterium tuberculosis |
purified recombinant wild-type and SeMet-labeled enzyme FbiD in apoform and in complex with phosphoenolpyruvate, X-ray diffraction structure determination and analysis at 1.99-2.33 A resolution | Mycobacterium tuberculosis |
Protein Variants | Comment | Organism |
---|---|---|
additional information | expression of the enzyme and by construction of a functional F420 biosynthetic pathway in Escherichia coli, an organism that does not normally produce F420, at levels comparable to some native F420-producing organisms | Methanocaldococcus jannaschii |
additional information | expression of the enzyme and by construction of a functional F420 biosynthetic pathway in Escherichia coli, an organism that does not normally produce F420, at levels comparable to some native F420-producing organisms. Expression of fbiABCD is sufficient to produce F420 in Escherichia coli | Mycobacterium tuberculosis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
phosphoenolpyruvate + GTP | Methanocaldococcus jannaschii | - |
enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | Mycobacterium tuberculosis | - |
enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | Methanocaldococcus jannaschii NBRC 100440 | - |
enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | Methanocaldococcus jannaschii DSM 2661 | - |
enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | Methanocaldococcus jannaschii ATCC 43067 | - |
enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | Methanocaldococcus jannaschii JAL-1 | - |
enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | Mycobacterium tuberculosis H37Rv | - |
enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | Mycobacterium tuberculosis ATCC 25618 | - |
enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | Methanocaldococcus jannaschii JCM 10045 | - |
enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Methanocaldococcus jannaschii | Q58297 | Methanococcus jannaschii | - |
Methanocaldococcus jannaschii ATCC 43067 | Q58297 | Methanococcus jannaschii | - |
Methanocaldococcus jannaschii DSM 2661 | Q58297 | Methanococcus jannaschii | - |
Methanocaldococcus jannaschii JAL-1 | Q58297 | Methanococcus jannaschii | - |
Methanocaldococcus jannaschii JCM 10045 | Q58297 | Methanococcus jannaschii | - |
Methanocaldococcus jannaschii NBRC 100440 | Q58297 | Methanococcus jannaschii | - |
Mycobacterium tuberculosis | - |
- |
- |
Mycobacterium tuberculosis | P9WP83 | - |
- |
Mycobacterium tuberculosis ATCC 25618 | - |
- |
- |
Mycobacterium tuberculosis ATCC 25618 | P9WP83 | - |
- |
Mycobacterium tuberculosis H37Rv | P9WP83 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | enzyme Mj-CofC can also catalyze the reaction with ATP, albeit to a lesser extent. No activity with 2-phospho-L-lactate. The CofC enzyme is only active in the presence of FbiA, the inferred intermediate enolpyruvyldiphospho-5'-guanosine (EPPG) is expected to be unstable | Methanocaldococcus jannaschii | ? | - |
- |
|
additional information | enzyme Mtb-FbiD exclusively utilizes GTP to produce dehydro-F420-0. No activity with 2-phospho-L-lactate. The FbiD enzyme is only active in the presence of FbiA, the inferred intermediate enolpyruvyldiphospho-5'-guanosine (EPPG) is expected to be unstable | Mycobacterium tuberculosis | ? | - |
- |
|
additional information | enzyme Mj-CofC can also catalyze the reaction with ATP, albeit to a lesser extent. No activity with 2-phospho-L-lactate. The CofC enzyme is only active in the presence of FbiA, the inferred intermediate enolpyruvyldiphospho-5'-guanosine (EPPG) is expected to be unstable | Methanocaldococcus jannaschii NBRC 100440 | ? | - |
- |
|
additional information | enzyme Mj-CofC can also catalyze the reaction with ATP, albeit to a lesser extent. No activity with 2-phospho-L-lactate. The CofC enzyme is only active in the presence of FbiA, the inferred intermediate enolpyruvyldiphospho-5'-guanosine (EPPG) is expected to be unstable | Methanocaldococcus jannaschii DSM 2661 | ? | - |
- |
|
additional information | enzyme Mj-CofC can also catalyze the reaction with ATP, albeit to a lesser extent. No activity with 2-phospho-L-lactate. The CofC enzyme is only active in the presence of FbiA, the inferred intermediate enolpyruvyldiphospho-5'-guanosine (EPPG) is expected to be unstable | Methanocaldococcus jannaschii ATCC 43067 | ? | - |
- |
|
additional information | enzyme Mj-CofC can also catalyze the reaction with ATP, albeit to a lesser extent. No activity with 2-phospho-L-lactate. The CofC enzyme is only active in the presence of FbiA, the inferred intermediate enolpyruvyldiphospho-5'-guanosine (EPPG) is expected to be unstable | Methanocaldococcus jannaschii JAL-1 | ? | - |
- |
|
additional information | enzyme Mtb-FbiD exclusively utilizes GTP to produce dehydro-F420-0. No activity with 2-phospho-L-lactate. The FbiD enzyme is only active in the presence of FbiA, the inferred intermediate enolpyruvyldiphospho-5'-guanosine (EPPG) is expected to be unstable | Mycobacterium tuberculosis H37Rv | ? | - |
- |
|
additional information | enzyme Mtb-FbiD exclusively utilizes GTP to produce dehydro-F420-0. No activity with 2-phospho-L-lactate. The FbiD enzyme is only active in the presence of FbiA, the inferred intermediate enolpyruvyldiphospho-5'-guanosine (EPPG) is expected to be unstable | Mycobacterium tuberculosis ATCC 25618 | ? | - |
- |
|
additional information | enzyme Mj-CofC can also catalyze the reaction with ATP, albeit to a lesser extent. No activity with 2-phospho-L-lactate. The CofC enzyme is only active in the presence of FbiA, the inferred intermediate enolpyruvyldiphospho-5'-guanosine (EPPG) is expected to be unstable | Methanocaldococcus jannaschii JCM 10045 | ? | - |
- |
|
phosphoenolpyruvate + GTP | - |
Mycobacterium tuberculosis | enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | - |
Methanocaldococcus jannaschii | enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | - |
Methanocaldococcus jannaschii NBRC 100440 | enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | - |
Methanocaldococcus jannaschii DSM 2661 | enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | - |
Methanocaldococcus jannaschii ATCC 43067 | enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | - |
Methanocaldococcus jannaschii JAL-1 | enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | - |
Mycobacterium tuberculosis H37Rv | enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | - |
Mycobacterium tuberculosis ATCC 25618 | enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? | |
phosphoenolpyruvate + GTP | - |
Methanocaldococcus jannaschii JCM 10045 | enolpyruvoyl-2-diphospho-5'-guanosine + diphosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
cofC | - |
Methanocaldococcus jannaschii |
fbiD | - |
Mycobacterium tuberculosis |
fbiD | - |
Methanocaldococcus jannaschii |
guanylyltransferase | - |
Methanocaldococcus jannaschii |
guanylyltransferase | - |
Mycobacterium tuberculosis |
Mj-CofC | - |
Methanocaldococcus jannaschii |
MJ0887 | - |
Methanocaldococcus jannaschii |
More | cf. 2.7.7.68 | Methanocaldococcus jannaschii |
Mtb-FbiD | - |
Mycobacterium tuberculosis |
Rv2983 | - |
Mycobacterium tuberculosis |
General Information | Comment | Organism |
---|---|---|
evolution | structure comparisons of bacterial FbiD and archaeal CofC enzymes. Mtb-FbiD adopts the same MobA-like nucleoside triphosphate transferase family protein fold as CofC: central 7-stranded beta-sheet (six parallel strands and one antiparallel), with alpha-helices packed on either side. But Mtb-FbiD lacks the protruding hairpin that is important for dimer formation in CofC | Methanocaldococcus jannaschii |
evolution | structure comparisons of bacterial FbiD and archaeal CofC enzymes. Mtb-FbiD adopts the same MobA-like nucleoside triphosphate transferase family protein fold as CofC: central 7-stranded beta-sheet (six parallel strands and one antiparallel), with alpha-helices packed on either side. But Mtb-FbiD lacks the protruding hairpin that is important for dimer formation in CofC | Mycobacterium tuberculosis |
metabolism | archaeal guanylyltransferase CofC, along with its the bacterial homologue FbiD, accepts ohosphoenolpyruvate, rather than 2-phospho-L-lactate, as the substrate, leading to the formation of the intermediate dehydro-F420-0. The enzyme is involved in the F420-0 biosynthetic pathway, overview. Dehydro-F420-0 is a bona fide metabolic intermediate that can be converted to mature F420 by FbiB in an FMNH2-dependent fashion | Methanocaldococcus jannaschii |
metabolism | the guanylyltransferase FbiD, along with its archaeal homologue CofC, accepts phosphoenolpyruvate, rather than 2-phospho-L-lactate, as the substrate, leading to the formation of the intermediate dehydro-F420-0. The C-terminal domain of FbiB then utilizes FMNH2 to reduce dehydro-F420-0, which produces mature F420 species when combined with the gamma-glutamyl ligase activity of the N-terminal domain. The enzyme is involved in the F420-0 biosynthetic pathway, overview. Dehydro-F420-0 is a bona fide metabolic intermediate that can be converted to mature F420 by FbiB in an FMNH2-dependent fashion | Mycobacterium tuberculosis |
additional information | docking of dehydro-F420-0 into the FMNH2-bound structure of FbiD. The methylene group of dehydro F420-0 is accommodated by a small hydrophobic pocket mostly comprised of P289 and M372 allowing it to be positioned above the N5 atom of FMNH2, in a plausible Michaelis complex for hydride transfer. The phosphoenolpyruvyl group of dehydro-F420-0 most likely samples conformations within this pocket where it can be reduced | Mycobacterium tuberculosis |
physiological function | guanylyltransferase FbiD accepts phosphoenolpyruvate, rather than 2-phospho-L-lactate, as the substrate, leading to the formation of the intermediate dehydro-F420-0. The C-terminal domain of gamma-glutamyl ligase FbiB then utilizes FMNH2 to reduce dehydro-F420-0, which produces mature F420 species when combined with the gamma-glutamyl ligase activity of the N-terminal domain. Expression of the FbiABCD cluster is sufficient to produce F420 in Escherichia coli | Mycobacterium tuberculosis |
physiological function | archaeal guanylyltransferase CofC, along with its the bacterial homologue FbiD, accepts phosphoenolpyruvate, rather than 2-phospho-L-lactate, as the substrate, leading to the formation of the intermediate dehydro-F420-0 | Methanocaldococcus jannaschii |
physiological function | the guanylyltransferase FbiD, along with its archaeal homologue CofC, accepts phosphoenolpyruvate, rather than 2-phospho-L-lactate, as the substrate, leading to the formation of the intermediate dehydro-F420-0 | Mycobacterium tuberculosis |